Salvatore Siena
机构: Università degli Studi di Milano, Dipartimento di Oncologia, Ospedale Niguarda, Milano, Italy
主页: unimi.it
每年引用次数
引用次数
引用: 86,737
H-指数: 113
I10-指数 : 428
出版物: 995
Treatment of metastatic neuroendocrine carcinomas based on WHO classification
Angelo Vanzulli , Marcello Gambacorta , Silvio Veronese , Salvatore Pisconti
Anticancer Research 25 4463 -4469
28
2005
Molecularly targeted therapies for colorectal cancer: Strategies for implementing translational research in clinical trials.
Heinz Zwierzina , Alberto Bardelli , Fortunato Ciardiello , Manuela Gariboldi
Current Opinion in Molecular Therapeutics 12 ( 6) 703 -711
1
2010
A combined analysis of two pivotal randomized trials of a single dose of pegfilgrastim per chemotherapy cycle and daily Filgrastim in patients with stage II-IV breast cancer.
Martine J. Piccart , John Glaspy , Frankie A. Holmes , Salvatore Siena
Oncology Reports 10 ( 3) 715 -724
95
2003
Epidermal growth factor receptor gene copy number
Alberto Bardelli , Salvatore Siena , Mauro Moroni
22
2006
Palliative treatment for elderly patients with colon cancer in ten Italian medical oncology units.
Marco Platania , Incoronata Romaniello , Giovanna Luchena , Rita Biason
Anticancer Research 28 1813 -1820
3
2008
Panitumumab with FOLFOX4 versus FOLFOX4 alone as first-line treatment for metastatic colorectal cancer (mCRC): results from the randomised phase III PRIME study
Jennifer Gansert , Mario E. Barugel , James Cassidy , David Cunningham
Onkologie : international journal for cancer research and treatment 33 68 -69
2010
Prime study : a randomised phase 3 study of panitumumab with Folfox4 versus Folfox4 alone as first line treatment for metastatic colorectal cancer (mCRC)
Jennifer Gansert , Mario E. Barugel , James Cassidy , David Cunningham
Annals of Oncology 21
1
2010
Autologous Dendritic Cells Derived from CD34+ Progenitors and from Monocytes Are Not Functionally Equivalent Antigen-presenting Cells in the Induction of Melan-A/Mart-127–35-specific CTLs from Peripheral Blood Lymphocytes of Melanoma Patients with Low Frequency of CTL Precursors
Roberta Mortarini , Andrea Anichini , Giorgio Parmiani , Alessandro M. Gianni
Cancer Research 57 ( 24) 5534 -5541
101
1997
Neuroimaging Abnormalities in Adult Medulloblastoma Undergoing Intensified Therapy
Simona Secondino , Alberto Citterio , Paolo Pedrazzoli , Salvatore Siena
Anticancer Research 28 3991 -3992
2008
K-ras and B-raf mutations and anti-EGFr antibody therapy
Alberto Bardelli , Salvatore Siena
26
2008
New reciprocal translocation t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia
Gabriella Sammarelli , Massimo Roncalli , Maria Grazia Grimoldi , Roberta Schiavo
Haematologica 84 ( 4) 369 -372
18
1999
Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors
Marcello Gambacorta , Silvio Veronese , Ornella Carminati , Roberta Schiavo
Clinical Cancer Research 7 ( 9) 2770 -2775
45
2001
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis.
Vittorio Perfetti , Laura Obici , Michele Magni , Giampaolo Merlini
Haematologica 91 ( 12) 1635 -1643
36
2006
Establishment and characterization of a new Ewing's sarcoma cell line from a malignant pleural effusion
Fabio Bozzi , Ines Chiara Andreotti , Paolo Pedrazzoli , Cinzia Tullio
Anticancer Research 27 3273 -3278
6
2007
Aspirin for colorectal cancer with PIK3CA mutations: the rising of the oldest targeted therapy?
Alessio Amatu , Andrea Sartore-Bianchi , Salvatore Siena , Katia Bencardino
Annals of Translational Medicine 1 ( 2) 12
5
2013
Treatment effect of panitumumab in subsets by epidermal growth factor receptor (EGFR) status from a phase 3 randomized controlled trial
Eric Van Cutsem , Bart Neyns , Joan Maurel , Jean-Luc Van Laethem
Annals of Oncology 17 249 -249
3
2006
Comparability testing of KRAS mutations and association with efficacy from a phase 3 randomized trial of panitumumab (pmab)
Eric Van Cutsem , Ildiko Sarosi , Kelly Oliner , Marc Peeters
The FASEB Journal 23
1
2009
Therapeutic targeting of epidermal growth factor receptor with monoclonal antibodies.
Angelo Vanzulli , Giovanna Marrapese , Simona Secondino , Paolo Pedrazzoli
I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.] 1 ( 4)
2002
4th National Conference of Medical Oncology. Evolution of the technology and clinical objectives of antitumor therapy
Salvatore Siena , Francesco Ferraù
Tumori 88 ( 6)
2002
Circulating hemopoietic progenitors mobilized by cancer chemotherapy and by rhGM-CSF in the treatment of high-grade non-Hodgkin's lymphoma.
Alessandro M. Gianni , Michele Magni , Salvatore Siena , Marco Bregni
Leukemia 5 123 -127
11
1991